Frequently Asked Questions
Didn’t find your answer here?
In the early days of peptide drug hunting there was a lack of significant connectivity and only limited “collective efforts” existing between academia, biotech, pharma, investors, contract R&D organizations, and service providers. We have now launched the PDHC to create a worldwide enterprise of peptide drug hunters that will become a multidisciplinary “collective genius” and a game changer for future peptide medicines.
The Entrepreneurial Advisory Board (EAB) consists of top scientists across peptide chemistry, biochemistry, structural biology, computational chemistry, pharmacology, pharmacokinetics, metabolism, delivery, toxicology, and drug development. These individuals along with the PDHC leadership team will support our scientific initiatives and foster collaboration. EAB membership is granted through a nomination process with final approval by the PDHC leadership team and the nominated individual’s company management.
The Entrepreneurial Business Network (EBN) was formed to help bridge the gap between science and business. Companies in the network (e.g., contract R&D organizations and service providers) are leaders in supporting peptide drug discovery. Please contact us if you would like your company represented. Company management approval is needed for EBN membership.
The PDHC is a nonprofit organization (501(c)3 pending) that will only succeed through sponsorships to support our multidisciplinary initiatives and membership operations. Sponsorship is $1,000 per year, and we invite pharma, biotech, investors, contract R&D organizations and service providers to donate to this great cause to advance the discovery of peptide medicines worldwide. Please contact us to arrange sponsorship.
NO! No priority information is to be shared in any aspect of the PDHC’s activities (e.g., website, emails, conversations, chronicle and initiatives). Please keep all priority information 100% confidential!